<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJL</journal-id>
<journal-id journal-id-type="hwp">spijl</journal-id>
<journal-id journal-id-type="nlm-ta">Int J Low Extrem Wounds</journal-id>
<journal-title>The International Journal of Lower Extremity Wounds</journal-title>
<issn pub-type="ppub">1534-7346</issn>
<issn pub-type="epub">1552-6941</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1534734612438436</article-id>
<article-id pub-id-type="publisher-id">10.1177_1534734612438436</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Multidisciplinary Lymphedema Treatment Program</article-title>
</title-group>
<contrib-group content-type="issue">
<contrib contrib-type="guest-editor">
<name><surname>Lazarides</surname><given-names>Miltos K.</given-names></name>
<degrees>MD, PhD</degrees>
</contrib>
</contrib-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Papadopoulou</surname><given-names>Maria-Christina</given-names></name>
<xref ref-type="aff" rid="aff1-1534734612438436">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Tsiouri</surname><given-names>Ioanna</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff1-1534734612438436">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Salta-Stankova</surname><given-names>Roumiana</given-names></name>
<xref ref-type="aff" rid="aff1-1534734612438436">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Drakou</surname><given-names>Aikaterini</given-names></name>
<degrees>MD, MSc</degrees>
<xref ref-type="aff" rid="aff1-1534734612438436">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Rousas</surname><given-names>Nikolaos</given-names></name>
<degrees>MD, MSc</degrees>
<xref ref-type="aff" rid="aff1-1534734612438436">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Roussaki-Schulze</surname><given-names>Aggeliki-Victoria</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-1534734612438436">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Giannoukas</surname><given-names>Athanasios D.</given-names></name>
<degrees>MSc, MD, PhD, FEBVS</degrees>
<xref ref-type="aff" rid="aff1-1534734612438436">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1534734612438436"><label>1</label>University Hospital of Larissa, Larissa, Greece</aff>
<author-notes>
<corresp id="corresp1-1534734612438436">Athanasios D. Giannoukas, Department of Vascular Surgery, University Hospital of Larissa, Mezourlo, Larissa, P.C. 41110, Greece Email: <email>giannouk@med.uth.gr</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2012</year>
</pub-date>
<volume>11</volume>
<issue>1</issue>
<issue-title>Special Issue on Lymphedema</issue-title>
<fpage>20</fpage>
<lpage>27</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Lymphedema is an underrecognized and undertreated condition that requires a multidisciplinary approach in an individualized program that will address the special needs of each patient. In an ideal setting of an outpatient management program the team should be composed of a vascular surgeon, a dermatologist, a physiotherapist, a dietician, a psychologist, a social worker, and an office employee, working together in the assessment and management of all aspects of lymphedema. All treatment strategies and actions taken should ultimately focus on the improvement of the quality of life of patients suffering from lymphedema and on the prevention of lymphedema in high-risk patients.</p>
</abstract>
<kwd-group>
<kwd>lymphedema</kwd>
<kwd>clinic</kwd>
<kwd>outpatient</kwd>
<kwd>hospital</kwd>
<kwd>program</kwd>
<kwd>unit</kwd>
<kwd>multidisciplinary</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1534734612438436" sec-type="intro">
<title>Introduction</title>
<p>Lymphedema is a relatively common, chronic, underrecognized, and undertreated condition<sup><xref ref-type="bibr" rid="bibr1-1534734612438436">1</xref>,<xref ref-type="bibr" rid="bibr2-1534734612438436">2</xref></sup> that occurs as a result of the body’s inability to drain lymph fluid from the tissues.<sup><xref ref-type="bibr" rid="bibr3-1534734612438436">3</xref></sup> The incidence of lymphedema reported in different studies varies widely as a result of the diversity in cancer treatment and measurement methods.<sup><xref ref-type="bibr" rid="bibr4-1534734612438436">4</xref></sup> For instance, lower limb lymphedema in women who have undergone gynecologic cancer treatment varies between 9% and 41%.<sup><xref ref-type="bibr" rid="bibr5-1534734612438436">5</xref></sup></p>
</sec>
<sec id="section2-1534734612438436">
<title>Management</title>
<p>Without proper treatment lymphedema can lead to severe swelling, fibrosis, skin changes, and infections.<sup><xref ref-type="bibr" rid="bibr6-1534734612438436">6</xref>,<xref ref-type="bibr" rid="bibr7-1534734612438436">7</xref></sup> Despite the fact that there is no cure for lymphedema, early identification and management are crucial.<sup><xref ref-type="bibr" rid="bibr8-1534734612438436">8</xref></sup> Also, there are numerous treatment options available for alleviating the consequences of lymphedema. Means and techniques used in the diagnosis, assessment, and treatment of lymphedema vary, and there have been several authors reviewing and listing them.<sup><xref ref-type="bibr" rid="bibr2-1534734612438436">2</xref>,<xref ref-type="bibr" rid="bibr3-1534734612438436">3</xref>,<xref ref-type="bibr" rid="bibr9-1534734612438436">9</xref><xref ref-type="bibr" rid="bibr10-1534734612438436"/>-<xref ref-type="bibr" rid="bibr11-1534734612438436">11</xref></sup> There are also different ways of treatment, such as the Földi,<sup><xref ref-type="bibr" rid="bibr12-1534734612438436">12</xref></sup> the Voder,<sup><xref ref-type="bibr" rid="bibr13-1534734612438436">13</xref></sup> the Casley-Smith,<sup><xref ref-type="bibr" rid="bibr14-1534734612438436">14</xref></sup> the Leduc,<sup><xref ref-type="bibr" rid="bibr15-1534734612438436">15</xref></sup> and the Godoy<sup><xref ref-type="bibr" rid="bibr16-1534734612438436">16</xref></sup> methods. The basic principles followed by these schools of therapy are the same, although they differ in the massage technique, the use of intermittent pneumatic pressure pumps in the Leduc method and the use of benzopyrone medication in the Casley-Smith method.<sup><xref ref-type="bibr" rid="bibr4-1534734612438436">4</xref></sup></p>
<p>Management guidelines have been given<sup><xref ref-type="bibr" rid="bibr17-1534734612438436">17</xref>,<xref ref-type="bibr" rid="bibr18-1534734612438436">18</xref></sup> and international consensus documents have been issued by the International Society of Lymphology<sup><xref ref-type="bibr" rid="bibr19-1534734612438436">19</xref>,<xref ref-type="bibr" rid="bibr20-1534734612438436">20</xref></sup> and the Lymphoe-dema Framework<sup><xref ref-type="bibr" rid="bibr21-1534734612438436">21</xref></sup> concerning the diagnosis and treatment of lymphedema. The latter is being updated and expanded by the American Lymphedema Framework Project,<sup><xref ref-type="bibr" rid="bibr22-1534734612438436">22</xref></sup> and it is estimated to be launched in 2012 as mentioned at the International Lymphoedema Framework Conference 2011 in Toronto, Canada.</p>
<sec id="section3-1534734612438436">
<title>Complete Decongestive Treatment</title>
<p>The reviews and consensus documents, as well as the different aforementioned methods recognize complete decongestive therapy (CDT) as the core of every management program for lymphedema. CDT involves 4 components (1) skin care and infection treatment, (2) special form of massage called manual lymph drainage (MLD), (3) compression bandaging and garment, and (4) special exercises. It is divided into 2 phases: an <italic>intensive treatment phase</italic>, including all the 4 components for achieving the reduction, and a <italic>maintenance phase</italic>, including self-care and MLD. Apart from these 4 main components the treatment includes assessment by physician, physical examination, measurement and documentation, additional medical treatment, instruction in nutrition, additional psychological advice, supervision of additional secondary pathological problems, and additional physiotherapeutic treatments.<sup><xref ref-type="bibr" rid="bibr13-1534734612438436">13</xref></sup> There have been several research protocols,<sup><xref ref-type="bibr" rid="bibr23-1534734612438436">23</xref><xref ref-type="bibr" rid="bibr24-1534734612438436"/><xref ref-type="bibr" rid="bibr25-1534734612438436"/><xref ref-type="bibr" rid="bibr26-1534734612438436"/><xref ref-type="bibr" rid="bibr27-1534734612438436"/><xref ref-type="bibr" rid="bibr28-1534734612438436"/><xref ref-type="bibr" rid="bibr29-1534734612438436"/>-<xref ref-type="bibr" rid="bibr30-1534734612438436">30</xref></sup> case reports,<sup><xref ref-type="bibr" rid="bibr31-1534734612438436">31</xref>,<xref ref-type="bibr" rid="bibr32-1534734612438436">32</xref></sup> reviews,<sup><xref ref-type="bibr" rid="bibr1-1534734612438436">1</xref>,<xref ref-type="bibr" rid="bibr11-1534734612438436">11</xref>,<xref ref-type="bibr" rid="bibr22-1534734612438436">22</xref>,<xref ref-type="bibr" rid="bibr33-1534734612438436">33</xref></sup> and reports<sup><xref ref-type="bibr" rid="bibr3-1534734612438436">3</xref>,<xref ref-type="bibr" rid="bibr4-1534734612438436">4</xref>,<xref ref-type="bibr" rid="bibr17-1534734612438436">17</xref>,<xref ref-type="bibr" rid="bibr34-1534734612438436">34</xref>,<xref ref-type="bibr" rid="bibr35-1534734612438436">35</xref></sup> concerning CDT.</p>
</sec>
</sec>
<sec id="section4-1534734612438436">
<title>Multidisciplinary Approach</title>
<p>Independent of the means of assessment and methods of treatment that will be chosen by each therapist or each group of therapists, the management of lymphedema requires a multidisciplinary<sup><xref ref-type="bibr" rid="bibr36-1534734612438436">36</xref>,<xref ref-type="bibr" rid="bibr37-1534734612438436">37</xref></sup> and a multimodal<sup><xref ref-type="bibr" rid="bibr23-1534734612438436">23</xref></sup> approach in an individualized program that will address the special needs of each patient and will allow a safe and effective implementation. This is because lymphedema, if untreated, can cause serious disturbances in patient’s quality of life, with additional consequences of psychological distress, depression, social isolation or inhibition, and sexuality concerns.<sup><xref ref-type="bibr" rid="bibr38-1534734612438436">38</xref></sup> Research has shown, especially for patients who have survived cancer, that disfigurement because of untreated lymphedema can be a secondary blow to their emotional well-being, causing anxiety symptoms, depression, and functional disability in their daily life (difficulty in domestic, vocational, social, and sexual domains).<sup><xref ref-type="bibr" rid="bibr39-1534734612438436">39</xref>,<xref ref-type="bibr" rid="bibr40-1534734612438436">40</xref></sup> Psychological and functional morbidity worsen when patients lack social support, since the feeling of isolation may heighten the avoidance and social withdrawal associated with lymphedema.<sup><xref ref-type="bibr" rid="bibr40-1534734612438436">40</xref></sup> Therefore, it is crucial that patients who develop lymphedema are assessed in terms of the psychosocial aspects of their lives, for a comprehensive and effective treatment.</p>
<p>Mental health professionals, along with other members of the treatment team, should work together to help patients cope with rehabilitative efforts, which require persistence and compliance by the patient. Individual or group psychoeducation can promote self-management skills, which is the main aspect of an effective multimodal rehabilitative treatment for patients with lymphedema.<sup><xref ref-type="bibr" rid="bibr23-1534734612438436">23</xref></sup> On the other hand, patients who experience severe anxiety or depression symptoms might need more extensive psychological interventions that mainly focus on issues related to negative body image, low self-esteem, and feelings of worthless-ness combined if necessary with psychopharmachological treatment.<sup><xref ref-type="bibr" rid="bibr38-1534734612438436">38</xref></sup></p>
<p>There are a few analytical reports about complete organized treatment programs that have intergraded CDT and some other components of treatment in an outpatient hospital setting for adult patients with lymphedema.</p>
<p>Brennan<sup><xref ref-type="bibr" rid="bibr41-1534734612438436">41</xref></sup> recommends the multidisciplinary approach that is being used at the Memorial Sloan Kettering Cancer Centre, involving physicians, occupational therapists, physical therapists, social workers, psychologists, and pain specialists. The treatment is divided into 3 phases namely, evaluation, intensive treatment, and maintenance. The assessment and diagnosis are being made by a physician and an occupational therapist. The therapy consists of daily and prolonged use of the pump first at the hospital and afterward at home, and the maintenance phase is about wearing the garment up to 22 hours per day and 0.5 to 2 hours daily use of the pump. According to their experience, this program provides and sustains greater than 50% reduction of lymphedema over a 1-year period, but in the article there was no further information about the program and the role of each specialist.</p>
<p>Brennan and Miller<sup><xref ref-type="bibr" rid="bibr9-1534734612438436">9</xref></sup> in their article stated that to meet the physical, functional, and emotional needs of these patients it is necessary to deliver a comprehensive treatment by a multidisciplinary team. A thorough assessment of these 3 aspects should always precede the treatment regimen. The core of the treatment will be compression garments in combination with an intermitted pneumatic compression pumps program, while individualized exercise program, retrograde massage, appropriate address of medical comorbidities, and psychiatric and/or psychological therapies and referral will be added if needed.</p>
<p>A hospital-based lymphedema service at the Royal Marsden Hospital is presented by Woods.<sup><xref ref-type="bibr" rid="bibr42-1534734612438436">42</xref></sup> Assessment and evaluation of response to treatment is being done at regular intervals with limb volume measurements (cylinder calculation), with a computerized imaging system, and by the patient’ subjective assessment of the swollen limb. The treatment modalities that are included in the service are education on skin care, treatment of inflammation or infection, movement and positioning, simple self-massage and external support in terms of bandaging or hosiery.</p>
<p>Vignes et al<sup><xref ref-type="bibr" rid="bibr43-1534734612438436">43</xref></sup> presented the lymphedema program at the Cognacq-Jay Hopsital in Paris, France. The members of the team are physicians, kinesiotherapists, and foot therapists (pedicurists), and they all participate at a first educational meeting about lymphedema and hygiene, where they also advice on weight loss. The assessment is being done by means of volumetry and circumferential measurements. The intensive phase of decongestive physiotherapy lasts 14 to 21 days and the patient visits the facilities 3 to 5 days per week for bandaging, exercise, pedicure, and skin care. A session with a psychologist is proposed where 2 assessment forms are being used, as well as relaxation techniques in group or individually.</p>
<p>Evrard-Bras et al<sup><xref ref-type="bibr" rid="bibr44-1534734612438436">44</xref></sup> in their article presented the lymphedema program at the Saint-Eloi Hospital at Montpellier, France. The attack phase includes circumference measurement, photographs, and 5 to 10 days of MLD, tissue mobilization, skin care, bandages, exercise, and hygiene care education. The maintenance phase aims to stabilize the previous results with daily use of a compression garment and exercise 3 days per week, reference to podologist, dietician, dermatologist, oncologist, dentist, and psychologist if needed. The third phase (autonomy) aims to encourage the patient to actively participate and to become more independent.</p>
<p>Strauss-Blasche et al<sup><xref ref-type="bibr" rid="bibr45-1534734612438436">45</xref></sup> present an inpatient 21-day rehabilitation program for breast cancer patients with or without lymphedema. During the program, though it is individualized, 90% of the patients have 16 sessions of MLD, 6 to 8 exercise sessions, 8 classical massage sessions, 3 two-hour cancer specific group counseling sessions, 6 half-hour muscle relaxation sessions, and 1 to 2 individual counseling sessions, as well as carbon dioxide baths and hot mud packs. There have been even more reports on multidisciplinary outpatient lymphedema treatment program.<sup><xref ref-type="bibr" rid="bibr46-1534734612438436">46</xref>,<xref ref-type="bibr" rid="bibr47-1534734612438436">47</xref></sup></p>
</sec>
<sec id="section5-1534734612438436">
<title>Multidisciplinary Treatment Team (Larissa-Greece)</title>
<p>In the University General Hospital of Larissa, Hellas, we have organized an outpatient multidisciplinary treatment program for patients with lymphedema based on the successful example of the Nij Smellinghe Lymphoedema Clinic, in Drachten, The Netherlands. We intergraded the literature information and the treatment guidelines given by the Lymphoedema Framework Consensus Document<sup><xref ref-type="bibr" rid="bibr21-1534734612438436">21</xref></sup> and modified the program to meet the Greek reality as far as hospital budget and rules of operation, insurance coverage, import companies and availability of lymphedema products, climate, geographical location and therapist, patient and public mentality are concerned.</p>
<p>The multidisciplinary team consists of vascular surgeons, dermatologists, physiotherapists, a dietician, a psychologist, a social worker, and an office employee. They all take part not only in the treatment of lymphedema but also in the prevention strategy for secondary lymphedema after cancer treatment. The treatment program is individualized to meet the needs of each patient (medical history, edema characteristics, patient’s preferences, financial status, and place of residence), but the core of the program remains the same for all patients.</p>
<sec id="section6-1534734612438436">
<title>Diagnosis</title>
<p>The diagnosis of lymphedema is being done by the vascular surgeons or the dermatologists of the team at the outpatient department. Every patient with complaints of swollen limbs undergoes a full and complete history and physical exam. The assessment form included at the Lymphoedema Framework Consensus Document,<sup><xref ref-type="bibr" rid="bibr21-1534734612438436">21</xref></sup> was translated into the Greek language and slightly modified adding information such as venous insufficiency and changing the circumference measurement table. When the medical history and the edema characteristics are filled out in the assessment form by the vascular surgeon or the dermatologist, the patient is referred to the other members of the treatment team (physiotherapist, dietician, and psychologist) for further assessment.</p>
</sec>
<sec id="section7-1534734612438436">
<title>First Educational Session: Treatment Options</title>
<p>After the diagnosis of lymphedema (primary, secondary, phlebolymphostatic, or combined) is made and other forms of edema (cardiac, renal) are excluded, the patient is referred to the physiotherapy department where circumference measurements and a 30-minute education session take place. The patient is informed about lymphedema and treatment options.</p>
</sec>
<sec id="section8-1534734612438436">
<title>Home-Based Program</title>
<p>If the degree of edema can be managed with compression garments and a home-based program, the patient is not motivated enough or if the patient denies the intensive outpatient program, usually because of the distance of the home from the hospital, and time and financial difficulties, another 30-minute educational session will take place about aggravating and beneficial factors for lymphedema, home-based exercise regimen, and aerobic exercise (walking). Advice is given also in printed form and they will be reassessed by the physiotherapists every 3 months. These patients will be afterward referred to the dietician of the team for body weight assessment, nutritional advice, and weight loss program and they will be followed on a monthly basis until they reach the individual ideal weight. If the diagnosis of lymphedema was made by a vascular surgeon the patient will be referred to the dermatologists of the team for skin condition assessment, treatment, and skin care education. Several morbidities, such as cellulitis and bacterial and mycotic infections<sup><xref ref-type="bibr" rid="bibr26-1534734612438436">26</xref></sup> are appropriately addressed.</p>
</sec>
<sec id="section9-1534734612438436">
<title>Intensive Outpatient Program</title>
<p>If the degree of edema demands an intensive approach, the patient agrees to participate and he is motivated enough, and taking into account the absolute and relative contraindications, 3 to 4 weeks of intensive CDT will be scheduled. The goals of the treatment are reduction of the edema, prevention of further accumulation of edema, reduction and prevention of infection incidences as stated by Cohen et al<sup><xref ref-type="bibr" rid="bibr10-1534734612438436">10</xref></sup> and improvement of the patient’s quality of life. The second half of the first educational session by the physiotherapists will focus on options on bandaging material (the patient is provided with a list of the available materials to compare prices, since the bandaging material are scarcely covered by the insurance companies) and emphasize on the fact that there will be no cure, but amelioration and maintenance with daily use of compression garments after the intensive program is finished. Circumference measurements are taken and the patient is referred to the dermatologist and the dietician for assessment and advice, and then the procedure is the same as with the home-based program.</p>
<p>These patients will also be referred to the psychologist of the team for a pretreatment psychological assessment. The purpose of this assessment is mainly to investigate, psychosocial parameters of the patient’s life that should be taken into consideration before going into rehabilitative treatment. A semistructured interview with the patient investigates the perceived psychological distress that lymphedema symptoms have caused to the patient’s daily life. More particularly, issues related to the patient’s concerns regarding body image and appearance, self-worth, and self-confidence are discussed, taking into consideration demographic variables such as age, gender, educational level, vocational status, and life style in general. Special emphasis is given on the patient’s expectations of the treatment program, as far as body image and appearance, as well as improvement of daily function and social life are concerned. Family and social support available for the patient are also assessed to investigate the risk for social isolation and disempowerment when coping with lymphedema. After the interview is completed, psychometric instruments assessing depression and anxiety are administered to the patient in order to have a more objective measurement of possible mental health conditions frequently associated with lymphedema. Based on this initial assessment patients are either referred for a more extensive psychological and if necessary psychopharmacologic intervention, or are scheduled for a posttreatment (follow-up) appointment, to evaluate the extent to which their expectations from the rehabilitative treatment were met and the degree of improvement in their psychosocial well-being.</p>
<p>The CDT with an individualized program of compression bandaging, MLD, intermitted pneumatic compression pumps and exercise, as needed, as well as care to special issues such as pain and range of motion reduction, is held daily or 4 days per week for 3 or more successive weeks in a specially organized room with 2 medical beds, a treadmill, a static bicycle, a stepper, and an elliptical machine (<xref ref-type="fig" rid="fig1-1534734612438436">Figure 1</xref>).</p>
<fig id="fig1-1534734612438436" position="float">
<label>Figure 1.</label>
<caption>
<p>Treatment hall with minimum essential equipment</p>
</caption>
<graphic xlink:href="10.1177_1534734612438436-fig1.tif"/></fig>
<p>The first session includes assessment with circumference measurements and photograph. The reliability of various assessment techniques has been tested and to some extent compared with one another.<sup><xref ref-type="bibr" rid="bibr48-1534734612438436">48</xref>,<xref ref-type="bibr" rid="bibr49-1534734612438436">49</xref></sup> Even though there are many techniques available for the assessment we have chosen the circumference measurement over volumetry and perometry because it is easy, accessible, inexpensive, and can be used on a routine basis at our hospital.</p>
<p>The first session also includes the completion of a Quality of Life Assessment Scale which is repeated at the end of the intensive program, after 3 months, 6 months, and 1 year. Concerning the quality of life and the demonstrable diminution produced by lymphedema,<sup><xref ref-type="bibr" rid="bibr50-1534734612438436">50</xref></sup> we believe that our ultimate goal should be the improvement of life and the impact of our treatment in this aspect should be assessed. There are several assessment forms and questionnaires that have been used in the assessment of the quality of life in patients with lymphedema, such as the Functional Assessment of Cancer Therapy–Breast quality of life instrument,<sup><xref ref-type="bibr" rid="bibr30-1534734612438436">30</xref>,<xref ref-type="bibr" rid="bibr51-1534734612438436">51</xref>,<xref ref-type="bibr" rid="bibr52-1534734612438436">52</xref></sup> the SF-36, a generic quality of life instrument,<sup><xref ref-type="bibr" rid="bibr50-1534734612438436">50</xref>,<xref ref-type="bibr" rid="bibr53-1534734612438436">53</xref></sup> the Functional Living Index–Cancer,<sup><xref ref-type="bibr" rid="bibr23-1534734612438436">23</xref></sup> and the Euroqol-5D.<sup><xref ref-type="bibr" rid="bibr54-1534734612438436">54</xref></sup> There are also quality of life assessment forms specific for lymphedema, and since a Greek translation was needed we decided to ask for permission to translate and validate in Greek language the Freiburg Life Quality Assessment Form for Lymphoedema.<sup><xref ref-type="bibr" rid="bibr55-1534734612438436">55</xref></sup></p>
<p>A comprehensive educational session, apart from the daily given instructions, is provided by the physiotherapists at the second week of the program. Patients are educated to realistic goals<sup><xref ref-type="bibr" rid="bibr56-1534734612438436">56</xref></sup> concerning basic skin care, foot or hand care, infection prevention strategies, exercise, bandaging materials, and garments hygiene and wearing instructions, as well as daily living actions.</p>
<p>At the end of the intensive program patients are reassessed by the whole team separately. Improvements in limb circumference, skin condition, quality of life, weight, and psychosocial well-being are documented and gathered in the patient’s personal file for future use and data comparison at 3,6, and 12 months. The patients are also asked to complete a Visual Analogue Scale (1-10) concerning the satisfaction with the program. Currently, we are working on the translation of the Patient Benefit Index.<sup><xref ref-type="bibr" rid="bibr57-1534734612438436">57</xref>,<xref ref-type="bibr" rid="bibr58-1534734612438436">58</xref></sup></p>
</sec>
<sec id="section10-1534734612438436">
<title>Maintenance Phase: Reassessment</title>
<p>Patients are transitioned to the maintenance phase when no further improvement is seen in circumference measurements. Ultrasonography and volumetry have been used by others<sup><xref ref-type="bibr" rid="bibr28-1534734612438436">28</xref></sup> to define the transition to the second phase but this is not available in our service. In this phase we insist on the use of the garment only during the day, on skin care, on the continuation of the home-based exercise program, and on the infection risk factors prevention guidelines. It has been stated that the use of garment during the day and elastic bandages during the night are the cornerstone of the maintenance phase<sup><xref ref-type="bibr" rid="bibr59-1534734612438436">59</xref></sup> and are associated with better results.<sup><xref ref-type="bibr" rid="bibr60-1534734612438436">60</xref></sup> In our program only a small number of patients were willing to learn and exercise self-bandaging in daily life and this was attributed to the Greek mentality.</p>
<p>We follow the proposition of Casley-Smith et al<sup><xref ref-type="bibr" rid="bibr14-1534734612438436">14</xref></sup> about rehearsal of the program after 6 to 9 months. If the limb has not been reduced to the normal size by the first course of treatment, the course is repeated after allowing enough time to body’s connective tissue to remodel.</p>
</sec>
<sec id="section11-1534734612438436">
<title>Lymphedema Prevention Strategy</title>
<p>The prevention strategy concerns patients who have undergone cancer treatment and are at risk for developing lymphedema. Patients are referred by physicians, surgeons, or by the Department of Radiotherapy of our hospital. In the absence of lymphedema precaution and prevention should be emphasized, even though the available data are speculative,<sup><xref ref-type="bibr" rid="bibr4-1534734612438436">4</xref></sup> and the team’s goal is identification, education, and intervention, as these 3 components can be effective in the prevention of secondary lymphedema.<sup><xref ref-type="bibr" rid="bibr61-1534734612438436">61</xref></sup> At the University Breast Center of Franconia, Germany the occurrence and pathogenesis of lymphedema are explained prior to an operation for breast cancer, whereas information about prevention, lymph drainage, and additional use of compression garments are given 2 to 3 weeks after the end of cancer treatment with a single visit in the outpatient department. In the multidisciplinary treatment program in Larissa, a session is planned that combines individual risk assessment and identification, a discussion about the lymphatic system, education about early warning signs, and the introduction of risk minimization strategies, according to Box et al.<sup><xref ref-type="bibr" rid="bibr62-1534734612438436">62</xref></sup> Furthermore, the patient is referred to the dietician for weight control and nutrition advice and to the team’s psychologist. Attention is being paid to the way the advice is to be formulated in a positive manner in order to enhance the patient’s sense of control as stated at the American Cancer Society Lymphedema Workshop.<sup><xref ref-type="bibr" rid="bibr56-1534734612438436">56</xref></sup></p>
</sec>
<sec id="section12-1534734612438436">
<title>Other Issues</title>
<p>The social worker of the team is responsible for communicating and organizing the program, for finding ways to inform public about its existence and for finding the means to expand it. He addresses issues concerning patient’s difficulties and certain needs. He is in charge of the program’s Web page and the Facebook address and for answering any online inquires raised either from patients or from therapists. He is also in charge of every official document sent by or addressed to the multidisciplinary team.</p>
</sec>
<sec id="section13-1534734612438436">
<title>Report From 1 Year of Operation</title>
<p>The multidisciplinary lymphedema treatment program has been running officially for 1 year. A total of 70 patients were assessed and diagnosed with lymphedema of the upper or lower limb (20% and 80%, respectively). Of those patients with lower limb lymphedema, 32% had primary edema, 15% had phlebolymphostatic edema, 44% had secondary lymphedema, and 9% had lipolymphedema. From the patients initially referred to the program only 56% participated and completed the program. Only 7% of the patients did not meet the criteria for an intensive program and thus they were advised to follow a home-based program, whereas 36% of the patients did not want to participate because of lack of motivation, economic burden of the therapy, distance from the hospital, and the time-consuming therapy. The majority of those who completed the intensive phase of the program demonstrated 50% or more reduction in limb circumference (<xref ref-type="fig" rid="fig2-1534734612438436">Figure 2</xref>). In few patients the reduction was 70% to 80% and 2 patients reached a 100% reduction.</p>
<fig id="fig2-1534734612438436" position="float">
<label>Figure 2.</label>
<caption>
<p>A patient with secondary limb lymphedema treated for 3 weeks by the multidisciplinary treatment team</p>
</caption>
<graphic xlink:href="10.1177_1534734612438436-fig2.tif"/></fig>
<p>Patients had difficulties maintaining the reduction by self-care and in some cases the limb returned to its pretreatment size. Reasons of failure as mentioned by the patients were difficulties with the compression garments when the patient could not afford a custom-made one or when the patient depended on family’s assistance for wearing it. The majority of patients were compliant with the diet and nutritional advice and demonstrated weight loss in the first month and during the intensive phase, but also the majority of them gave up after the third month. All patients were satisfied with the intensive phase of the program but the satisfaction diminished after the first month of maintenance when it was expected to practice self-care. On the contrary, the results on the quality of life and psychosocial being were not that satisfactory, with only moderate improvement in the majority of the patients which was undersized by the time consuming self-care and the daily use of the compression garment. Satisfactory improvement in quality of life was noted only in patients with severe lymphedema.</p>
<p>The future goals of the multidisciplinary lymphedema treatment team include the following:</p>
<list id="list1-1534734612438436" list-type="simple">
<list-item><p>more thorough assessment using devices available in the market;</p></list-item>
<list-item><p>inpatient program or appropriate accommodation for patients coming from other parts of Greece;</p></list-item>
<list-item><p>improvement of the maintenance phase results, maybe with more frequent patient reassessment, more effective education to patient and family members, and new strategies to help the patient cope with imperative changes in life; and</p></list-item>
<list-item><p>evaluation of the factors that do not allow improvement in the quality of life and find ways to promote quality of life.</p></list-item>
</list>
</sec>
</sec>
<sec id="section14-1534734612438436" sec-type="conclusions">
<title>Conclusion</title>
<p>A multidisciplinary approach is the preferred choice for an outpatient lymphedema management program. A multidisciplinary program can be organized and run successfully, even on a low budget. The team must cooperate, have mutual goals, and use all the available literature data, as well as the experience from other outpatient programs, to improve and update the service provided to patients with lymphedema.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<p>The author(s) received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1534734612438436">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Moffatt</surname><given-names>CJ</given-names></name>
<name><surname>Franks</surname><given-names>PJ</given-names></name>
<name><surname>Doherty</surname><given-names>DC</given-names></name><etal/>
</person-group>. <article-title>Lymphoedema: an underestimated health problem</article-title>. <source>QJM</source>. <year>2003</year>;<volume>96</volume>:<fpage>731</fpage>-<lpage>738</lpage>.</citation>
</ref>
<ref id="bibr2-1534734612438436">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gary</surname><given-names>DE</given-names></name>
</person-group>. <article-title>Lymphedema diagnosis and management</article-title>. <source>J Am Acad Nurse Pract</source>. <year>2007</year>;<volume>19</volume>:<fpage>72</fpage>-<lpage>78</lpage>.</citation>
</ref>
<ref id="bibr3-1534734612438436">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lawenda</surname><given-names>BD</given-names></name>
<name><surname>Mondry</surname><given-names>TE</given-names></name>
<name><surname>Johnstone</surname><given-names>PA</given-names></name>
</person-group>. <article-title>Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment</article-title>. <source>CA Cancer J Clin</source>. <year>2009</year>;<volume>59</volume>:<fpage>8</fpage>-<lpage>24</lpage>.</citation>
</ref>
<ref id="bibr4-1534734612438436">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Petrek</surname><given-names>JA</given-names></name>
<name><surname>Pressman</surname><given-names>PI</given-names></name>
<name><surname>Smith</surname><given-names>RA</given-names></name>
</person-group>. <article-title>Lymphedema: current issues in research and management</article-title>. <source>CA Cancer J Clin</source>. <year>2000</year>;<volume>50</volume>:<fpage>292</fpage>-<lpage>307</lpage>.</citation>
</ref>
<ref id="bibr5-1534734612438436">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ryan</surname><given-names>M</given-names></name>
<name><surname>Stainton</surname><given-names>MC</given-names></name>
<name><surname>Slaytor</surname><given-names>EK</given-names></name>
<name><surname>Jaconelli</surname><given-names>C</given-names></name>
<name><surname>Watts</surname><given-names>S</given-names></name>
<name><surname>Mackenzie</surname><given-names>P</given-names></name>
</person-group>. <article-title>Aetiology and prevalence of lower limb lymphoedema following treatment for gynaecological cancer</article-title>. <source>Aust N Z J Obstet Gynaecol</source>. <year>2003</year>;<volume>43</volume>:<fpage>148</fpage>-<lpage>151</lpage>.</citation>
</ref>
<ref id="bibr6-1534734612438436">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Regnard</surname><given-names>C</given-names></name>
<name><surname>Allport</surname><given-names>S</given-names></name>
<name><surname>Stephenson</surname><given-names>L</given-names></name>
</person-group>. <article-title>ABC of palliative care. Mouth care, skin care, and lymphoedema</article-title>. <source>BMJ</source>. <year>1997</year>;<volume>315</volume>:<fpage>1002</fpage>-<lpage>1005</lpage>.</citation>
</ref>
<ref id="bibr7-1534734612438436">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>MacLaren</surname><given-names>JA</given-names></name>
</person-group>. <article-title>Skin changes in lymphoedema: pathophysiology and management options</article-title>. <source>Int J Palliat Nurs</source>. <year>2001</year>;<volume>7</volume>:<fpage>381</fpage>-<lpage>388</lpage>.</citation>
</ref>
<ref id="bibr8-1534734612438436">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Campisi</surname><given-names>C</given-names></name>
</person-group>. <article-title>Lymphoedema: modern diagnostic and therapeutic aspects</article-title>. <source>Int Angiol</source>. <year>1999</year>;<volume>18</volume>:<fpage>14</fpage>-<lpage>24</lpage>.</citation>
</ref>
<ref id="bibr9-1534734612438436">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brennan</surname><given-names>MJ</given-names></name>
<name><surname>Miller</surname><given-names>LT</given-names></name>
</person-group>. <article-title>Overview of treatment options and review of the current role and use of compression garments, intermittent pumps, and exercise in the management of lymphedema</article-title>. <source>Cancer</source>. <year>1998</year>;<volume>83</volume>(<issue>12 suppl</issue>):<fpage>2821</fpage>-<lpage>2827</lpage>.</citation>
</ref>
<ref id="bibr10-1534734612438436">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cohen</surname><given-names>SR</given-names></name>
<name><surname>Payne</surname><given-names>DK</given-names></name>
<name><surname>Tunkel</surname><given-names>RS</given-names></name>
</person-group>. <article-title>Lymphedema strategies for management</article-title>. <source>Cancer</source>. <year>1998</year>;<volume>83</volume>(<issue>4 suppl</issue>):<fpage>980</fpage>-<lpage>986</lpage>.</citation>
</ref>
<ref id="bibr11-1534734612438436">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cheifetz</surname><given-names>O</given-names></name>
<name><surname>Haley</surname><given-names>L</given-names></name>
</person-group>; <collab>Breast Cancer Action</collab>. <article-title>Management of secondary lymphedema related to breast cancer</article-title>. <source>Can Fam Physician</source>. <year>2010</year>;<volume>56</volume>:<fpage>1277</fpage>-<lpage>1284</lpage>.</citation>
</ref>
<ref id="bibr12-1534734612438436">
<label>12.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Földi</surname><given-names>M</given-names></name>
<name><surname>Földi</surname><given-names>E</given-names></name>
</person-group>. <source>Lymphoedema: Methods of Treatment and Control</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Gustav Fischer Verlag</publisher-name>; <year>1991</year>.</citation>
</ref>
<ref id="bibr13-1534734612438436">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kasseroller</surname><given-names>RG</given-names></name>
</person-group>. <article-title>The Vodder school: the Vodder method</article-title>. <source>Cancer</source>. <year>1998</year>;<volume>83</volume>(<issue>12 suppl</issue>):<fpage>2840</fpage>-<lpage>2842</lpage>.</citation>
</ref>
<ref id="bibr14-1534734612438436">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Casley-Smith</surname><given-names>JR</given-names></name>
<name><surname>Boris</surname><given-names>M</given-names></name>
<name><surname>Weindorf</surname><given-names>S</given-names></name>
<name><surname>Lasinski</surname><given-names>B</given-names></name>
</person-group>. <article-title>Treatment for lymphedema of the arm—the Casley-Smith method: a noninvasive method produces continued reduction</article-title>. <source>Cancer</source>. <year>1998</year>;<volume>83</volume>(<issue>12 suppl</issue>):<fpage>2843</fpage>-<lpage>2860</lpage>.</citation>
</ref>
<ref id="bibr15-1534734612438436">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Leduc</surname><given-names>O</given-names></name>
<name><surname>Leduc</surname><given-names>A</given-names></name>
<name><surname>Bourgeois</surname><given-names>P</given-names></name>
<name><surname>Belgrado</surname><given-names>J-P</given-names></name>
</person-group>. <article-title>The physical treatment of upper limb edema</article-title>. <source>Cancer</source>. <year>1998</year>;<volume>83</volume>(<issue>12 suppl</issue>):<fpage>2835</fpage>-<lpage>2839</lpage>.</citation>
</ref>
<ref id="bibr16-1534734612438436">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>De Godoy</surname><given-names>JM</given-names></name>
<name><surname>Batigalia</surname><given-names>F</given-names></name>
<name><surname>Godoy Mde</surname><given-names>F</given-names></name>
</person-group>. <article-title>Preliminary evaluation of a new, more simplified physiotherapy technique for lymphatic drainage</article-title>. <source>Lymphology</source>. <year>2002</year>;<volume>35</volume>:<fpage>91</fpage>-<lpage>93</lpage>.</citation>
</ref>
<ref id="bibr17-1534734612438436">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Granda</surname><given-names>C</given-names></name>
</person-group>. <article-title>Nursing management of patients with lymphedema associated with breast cancer therapy</article-title>. <source>Cancer Nurs</source>. <year>1994</year>;<volume>17</volume>:<fpage>229</fpage>-<lpage>235</lpage>.</citation>
</ref>
<ref id="bibr18-1534734612438436">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kirshbaum</surname><given-names>M</given-names></name>
</person-group>. <article-title>The development, implementation and evaluation of guidelines for the management of breast cancer related lymphoedema</article-title>. <source>Eur J Cancer Care (Engl)</source>. <year>1996</year>;<volume>5</volume>:<fpage>246</fpage>-<lpage>251</lpage>.</citation>
</ref>
<ref id="bibr19-1534734612438436">
<label>19.</label>
<citation citation-type="journal">
<collab>International Society of Lymphology</collab>. <article-title>The diagnosis and treatment of peripheral lymphedema: consensus document of the International Society of Lymphology</article-title>. <source>Lymphology</source>. <year>2003</year>;<volume>36</volume>:<fpage>84</fpage>-<lpage>91</lpage>.</citation>
</ref>
<ref id="bibr20-1534734612438436">
<label>20.</label>
<citation citation-type="journal">
<collab>International Society of Lymphology</collab>. <article-title>The diagnosis and treatment of peripheral lymphedema: 2009 consensus document of the International Society of Lymphology</article-title>. <source>Lymphology</source>. <year>2009</year>;<volume>42</volume>:<fpage>51</fpage>-<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr21-1534734612438436">
<label>21.</label>
<citation citation-type="book">
<collab>Lymphoedema Framework</collab>. <source>Best Practice for the Managementof Lymphoedema: International Consesus</source>. <publisher-loc>London, England</publisher-loc>: <publisher-name>MEP</publisher-name>; <year>2006</year>.</citation>
</ref>
<ref id="bibr22-1534734612438436">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cormier</surname><given-names>G</given-names></name>
<name><surname>Feldman</surname><given-names>J</given-names></name>
<name><surname>Askew</surname><given-names>R</given-names></name><etal/>
</person-group>. <article-title>ALFP to update the best practice document</article-title>. <source>J Lymphoedema.</source>,<year>2010</year>;<volume>5</volume>:<fpage>68</fpage>-<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr23-1534734612438436">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mirolo</surname><given-names>BR</given-names></name>
<name><surname>Bunce</surname><given-names>IH</given-names></name>
<name><surname>Chapman</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Psychosocial benefits of postmastectomy lymphedema therapy</article-title>. <source>Cancer Nurs</source>. <year>1995</year>;<volume>18</volume>:<fpage>197</fpage>-<lpage>205</lpage>.</citation>
</ref>
<ref id="bibr24-1534734612438436">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Matthews</surname><given-names>K</given-names></name>
<name><surname>Smith</surname><given-names>J</given-names></name>
</person-group>. <article-title>Effectiveness of modified complex physical therapy for lymphoedema treatment</article-title>. <source>Aust J Physiother</source>. <year>1996</year>;<volume>42</volume>:<fpage>323</fpage>-<lpage>328</lpage>.</citation>
</ref>
<ref id="bibr25-1534734612438436">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mondry</surname><given-names>TE</given-names></name>
<name><surname>Riffenburgh</surname><given-names>RH</given-names></name>
<name><surname>Johnstone</surname><given-names>PA</given-names></name>
</person-group>. <article-title>Prospective trial of complete decongestive therapy for upper extremity lymphedema after breast cancer therapy</article-title>. <source>Cancer J</source>. <year>2004</year>;<volume>10</volume>:<fpage>42</fpage>-<lpage>48</lpage>.</citation>
</ref>
<ref id="bibr26-1534734612438436">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hamner</surname><given-names>JB</given-names></name>
<name><surname>Fleming</surname><given-names>MD</given-names></name>
</person-group>. <article-title>Lymphedema therapy reduces the volume of edema and pain in patients with breast cancer</article-title>. <source>Ann Surg Oncol</source>. <year>2007</year>;<volume>14</volume>:<fpage>1904</fpage>-<lpage>1908</lpage>.</citation>
</ref>
<ref id="bibr27-1534734612438436">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Koul</surname><given-names>R</given-names></name>
<name><surname>Dufan</surname><given-names>T</given-names></name>
<name><surname>Russell</surname><given-names>C</given-names></name><etal/>
</person-group>. <article-title>Efficacy of complete decongestive therapy and manual lymphatic drainage on treatment-related lymphedema in breast cancer</article-title>. <source>Int J Radiat Oncol Biol Phys</source>. <year>2007</year>;<volume>67</volume>:<fpage>841</fpage>-<lpage>846</lpage>.</citation>
</ref>
<ref id="bibr28-1534734612438436">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yamamoto</surname><given-names>R</given-names></name>
<name><surname>Yamamoto</surname><given-names>T</given-names></name>
</person-group>. <article-title>Effectiveness of the treatment-phase of two-phase complex decongestive physiotherapy for the treatment of extremity lymphedema</article-title>. <source>Int J Clin Oncol</source>. <year>2007</year>;<volume>12</volume>:<fpage>463</fpage>-<lpage>468</lpage>.</citation>
</ref>
<ref id="bibr29-1534734612438436">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Didem</surname><given-names>K</given-names></name>
<name><surname>Ufuk</surname><given-names>YS</given-names></name>
<name><surname>Serdar</surname><given-names>S</given-names></name>
<name><surname>Zümre</surname><given-names>A</given-names></name>
</person-group>. <article-title>The comparison of two different physiotherapy methods in treatment of lymphedema after breast surgery</article-title>. <source>Breast Cancer Res Treat</source>. <year>2005</year>;<volume>93</volume>:<fpage>49</fpage>-<lpage>54</lpage>.</citation>
</ref>
<ref id="bibr30-1534734612438436">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Karadibak</surname><given-names>D</given-names></name>
<name><surname>Yavuzsen</surname><given-names>T</given-names></name>
<name><surname>Saydam</surname><given-names>S</given-names></name>
</person-group>. <article-title>Prospective trial of intensive decongestive physiotherapy for upper extremity lymphedema</article-title>. <source>J Surg Oncol</source>. <year>2008</year>;<volume>97</volume>:<fpage>572</fpage>-<lpage>577</lpage>.</citation>
</ref>
<ref id="bibr31-1534734612438436">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Araújo</surname><given-names>JA</given-names></name>
<name><surname>Curbelo</surname><given-names>JG</given-names></name>
<name><surname>Mayol</surname><given-names>AL</given-names></name>
<name><surname>Pascal</surname><given-names>GG</given-names></name>
<name><surname>Vignale</surname><given-names>RA</given-names></name>
<name><surname>Fleurquin</surname><given-names>F</given-names></name>
</person-group>. <article-title>Effective management of marked lymphedema of the leg</article-title>. <source>Int J Dermatol</source>. <year>1997</year>;<volume>36</volume>:<fpage>389</fpage>-<lpage>392</lpage>.</citation>
</ref>
<ref id="bibr32-1534734612438436">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Holtgrefe</surname><given-names>KM</given-names></name>
</person-group>. <article-title>Twice-weekly complete decongestive physical therapy in the management of secondary lymphedema of the lower extremities</article-title>. <source>Phys Ther</source>. <year>2006</year>;<volume>86</volume>:<fpage>1128</fpage>-<lpage>1136</lpage>.</citation>
</ref>
<ref id="bibr33-1534734612438436">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Megens</surname><given-names>A</given-names></name>
<name><surname>Harris</surname><given-names>SR</given-names></name>
</person-group>. <article-title>Physical therapist management of lymphedema following treatment for breast cancer: a critical review of its effectiveness</article-title>. <source>Phys Ther</source>. <year>1998</year>;<volume>78</volume>:<fpage>1302</fpage>-<lpage>1311</lpage>.</citation>
</ref>
<ref id="bibr34-1534734612438436">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lerner</surname><given-names>R</given-names></name>
</person-group>. <article-title>Complete decongestive physiotherapy and the Lerner Lymphedema Services Academy of Lymphatic Studies (the Lerner school)</article-title>. <source>Cancer</source>. <year>1998</year>;<volume>83</volume> (<issue>12 suppl</issue>):<fpage>2861</fpage>-<lpage>2863</lpage>.</citation>
</ref>
<ref id="bibr35-1534734612438436">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Arrault</surname><given-names>M</given-names></name>
<name><surname>Vignes</surname><given-names>S</given-names></name>
</person-group>. <article-title>Management of lymphedema of the upper extremity after treatment of breast Cancer</article-title>. <source>Bull Cancer</source>. <year>2007</year>;<volume>94</volume>:<fpage>669</fpage>-<lpage>674</lpage>.</citation>
</ref>
<ref id="bibr36-1534734612438436">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Morrell</surname><given-names>RM</given-names></name>
<name><surname>Halyard</surname><given-names>MY</given-names></name>
<name><surname>Schild</surname><given-names>SE</given-names></name>
<name><surname>Ali</surname><given-names>MS</given-names></name>
<name><surname>Gunderson</surname><given-names>LL</given-names></name>
<name><surname>Pockaj</surname><given-names>BA</given-names></name>
</person-group>. <article-title>Breast cancer-related lymphedema</article-title>. <source>Mayo Clin Proc</source>. <year>2005</year>;<volume>80</volume>:<fpage>1480</fpage>-<lpage>1484</lpage>.</citation>
</ref>
<ref id="bibr37-1534734612438436">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ridner</surname><given-names>SH</given-names></name>
<name><surname>Dietrich</surname><given-names>MS</given-names></name>
<name><surname>Kidd</surname><given-names>N</given-names></name>
</person-group>. <article-title>Breast cancer treatment-related lymphedema self-care: education, practices, symptoms, and quality of life</article-title>. <source>Support Care Cancer</source>. <year>2011</year>;<volume>19</volume>: <fpage>631</fpage>-<lpage>637</lpage>.</citation>
</ref>
<ref id="bibr38-1534734612438436">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Passik</surname><given-names>SD</given-names></name>
<name><surname>McDonald</surname><given-names>MV</given-names></name>
</person-group>. <article-title>Psychosocial aspects of upper extremity lymphedema in women treated for breast carcinoma</article-title>. <source>Cancer</source>. <year>1998</year>;<volume>83</volume>(<issue>12 suppl</issue>):<fpage>2817</fpage>-<lpage>2820</lpage>.</citation>
</ref>
<ref id="bibr39-1534734612438436">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tobin</surname><given-names>M</given-names></name>
<name><surname>Lacey</surname><given-names>HJ</given-names></name>
<name><surname>Meyer</surname><given-names>L</given-names></name>
<name><surname>Mortimer</surname><given-names>PS</given-names></name>
</person-group>. <article-title>The psychological morbidity of breast cancer-related arm swelling</article-title>. <source>Cancer</source>. <year>1993</year>;<volume>72</volume>:<fpage>3248</fpage>-<lpage>3252</lpage>.</citation>
</ref>
<ref id="bibr40-1534734612438436">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Passik</surname><given-names>SD</given-names></name>
<name><surname>Newman</surname><given-names>M</given-names></name>
<name><surname>Brennan</surname><given-names>M</given-names></name>
<name><surname>Tunkel</surname><given-names>R</given-names></name>
</person-group>. <article-title>Predictors of psychological distress, sexual dysfunction and physical functioning among women with upper extremity lymphedema related to breast cancer</article-title>. <source>Psychooncology</source>. <year>1995</year>;<volume>4</volume>:<fpage>255</fpage>-<lpage>263</lpage>.</citation>
</ref>
<ref id="bibr41-1534734612438436">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brennan</surname><given-names>MJ</given-names></name>
</person-group>. <article-title>Lymphedema following the surgical treatment of breast cancer: a review of pathophysiology and treatment</article-title>. <source>J Pain Symptom Manage</source>. <year>1992</year>;<volume>7</volume>:<fpage>110</fpage>-<lpage>116</lpage>.</citation>
</ref>
<ref id="bibr42-1534734612438436">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Woods</surname><given-names>M</given-names></name>
</person-group>. <article-title>A hospital-based service for lymphoedema management</article-title>. <source>Eur J Cancer Care (Engl)</source>. <year>1993</year>;<volume>2</volume>:<fpage>165</fpage>-<lpage>168</lpage>.</citation>
</ref>
<ref id="bibr43-1534734612438436">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vignes</surname><given-names>S</given-names></name>
<name><surname>Champagne</surname><given-names>A</given-names></name>
<name><surname>Poisson</surname><given-names>O</given-names></name>
</person-group>. <article-title>Management of lymphedema: experience of the Cognacq-Jay hospital [in French]</article-title>. <source>Rev Med Interne</source>. <year>2002</year>;<volume>23</volume>(<issue>suppl 3</issue>):<fpage>414s</fpage>-<lpage>420s</lpage>.</citation>
</ref>
<ref id="bibr44-1534734612438436">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Evrard-Bras</surname><given-names>M</given-names></name>
<name><surname>Coupé</surname><given-names>M</given-names></name>
<name><surname>Quéré</surname><given-names>I</given-names></name>
<name><surname>Janbon</surname><given-names>C</given-names></name>
</person-group>. <article-title>Physical therapy of lymphedema: Montpellier’s experience [in French]</article-title>. <source>Rev Med Interne</source>. <year>2002</year>;<volume>23</volume>(<issue>suppl 3</issue>):<fpage>408s</fpage>-<lpage>413s</lpage>.</citation>
</ref>
<ref id="bibr45-1534734612438436">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Strauss-Blasche</surname><given-names>G</given-names></name>
<name><surname>Gnad</surname><given-names>E</given-names></name>
<name><surname>Ekmekcioglu</surname><given-names>C</given-names></name>
<name><surname>Hladschik</surname><given-names>B</given-names></name>
<name><surname>Marktl</surname><given-names>W</given-names></name>
</person-group>. <article-title>Combined inpatient rehabilitation and spa therapy for breast cancer patients: effects on quality of life and CA 15-3</article-title>. <source>Cancer Nurs</source>. <year>2005</year>;<volume>28</volume>:<fpage>390</fpage>-<lpage>398</lpage>.</citation>
</ref>
<ref id="bibr46-1534734612438436">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Williams</surname><given-names>AE</given-names></name>
<name><surname>Bergl</surname><given-names>S</given-names></name>
<name><surname>Twycross</surname><given-names>RG</given-names></name>
</person-group>. <article-title>A 5-year review of a lymphoedema service</article-title>. <source>Eur J Cancer Care (Engl)</source>. <year>1996</year>;<volume>5</volume>: <fpage>56</fpage>-<lpage>59</lpage>.</citation>
</ref>
<ref id="bibr47-1534734612438436">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bunce</surname><given-names>IH</given-names></name>
<name><surname>Mirolo</surname><given-names>BR</given-names></name>
<name><surname>Hennessy</surname><given-names>JM</given-names></name>
<name><surname>Ward</surname><given-names>LC</given-names></name>
<name><surname>Jones</surname><given-names>LC</given-names></name>
</person-group>. <article-title>Post-mastectomy lymphoedema treatment and measurement</article-title>. <source>Med J Aust</source>. <year>1994</year>;<volume>161</volume>:<fpage>125</fpage>-<lpage>128</lpage>.</citation>
</ref>
<ref id="bibr48-1534734612438436">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gerber</surname><given-names>LH</given-names></name>
</person-group>. <article-title>American Cancer Society Lymphedema Workshop. A review of measures of lymphedema</article-title>. <source>Cancer</source>. <year>1998</year>;<volume>83</volume>(<issue>12 suppl</issue>):<fpage>2803</fpage>-<lpage>2804</lpage>.</citation>
</ref>
<ref id="bibr49-1534734612438436">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tewari</surname><given-names>N</given-names></name>
<name><surname>Gill</surname><given-names>PG</given-names></name>
<name><surname>Bochner</surname><given-names>MA</given-names></name>
<name><surname>Kollias</surname><given-names>J</given-names></name>
</person-group>. <article-title>Comparison of volume displacement versus circumferential arm measurements for lymphoedema: implications for the SNAC trial</article-title>. <source>ANZ J Surg</source>. <year>2008</year>;<volume>78</volume>:<fpage>889</fpage>-<lpage>893</lpage>.</citation>
</ref>
<ref id="bibr50-1534734612438436">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Velanovich</surname><given-names>V</given-names></name>
<name><surname>Szymanski</surname><given-names>W</given-names></name>
</person-group>. <article-title>Quality of life of breast cancer patients with lymphedema</article-title>. <source>Am J Surg</source>. <year>1999</year>;<volume>177</volume>:<fpage>184</fpage>-<lpage>187</lpage>.</citation>
</ref>
<ref id="bibr51-1534734612438436">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Beaulac</surname><given-names>SM</given-names></name>
<name><surname>McNair</surname><given-names>LA</given-names></name>
<name><surname>Scott</surname><given-names>TE</given-names></name>
<name><surname>LaMorte</surname><given-names>WW</given-names></name>
<name><surname>Kavanah</surname><given-names>MT</given-names></name>
</person-group>. <article-title>Lymphedema and quality of life in survivors of early-stage breast cancer</article-title>. <source>Arch Surg</source>. <year>2002</year>;<volume>137</volume>:<fpage>1253</fpage>-<lpage>1257</lpage>.</citation>
</ref>
<ref id="bibr52-1534734612438436">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Taira</surname><given-names>N</given-names></name>
<name><surname>Shimozuma</surname><given-names>K</given-names></name>
<name><surname>Shiroiwa</surname><given-names>T</given-names></name><etal/>
</person-group>. <article-title>Associations among baseline variables, treatment-related factors and health-related quality of life 2 years after breast cancer surgery</article-title>. <source>Breast Cancer Res Treat</source>. <year>2011</year>;<volume>128</volume>:<fpage>735</fpage>-<lpage>747</lpage>.</citation>
</ref>
<ref id="bibr53-1534734612438436">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Symvoulakis</surname><given-names>EK</given-names></name>
<name><surname>Anyfantakis</surname><given-names>DI</given-names></name>
<name><surname>Lionis</surname><given-names>C</given-names></name>
</person-group>. <article-title>Primary lower limb lymphedema: a focus on its functional, social and emotional impact</article-title>. <source>Int J Med Sci</source>. <year>2010</year>;<volume>7</volume>:<fpage>353</fpage>-<lpage>357</lpage>.</citation>
</ref>
<ref id="bibr54-1534734612438436">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cheville</surname><given-names>AL</given-names></name>
<name><surname>Almoza</surname><given-names>M</given-names></name>
<name><surname>Courmier</surname><given-names>JN</given-names></name>
<name><surname>Basford</surname><given-names>JR</given-names></name>
</person-group>. <article-title>A prospective cohort study defining utilities using time trade-offs and the Euroqol-5D to assess the impact of cancer-related lymphedema</article-title>. <source>Cancer</source>. <year>2010</year>;<volume>116</volume>:<fpage>3722</fpage>-<lpage>3731</lpage>.</citation>
</ref>
<ref id="bibr55-1534734612438436">
<label>55.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Augustin</surname><given-names>M</given-names></name>
<name><surname>Bross</surname><given-names>F</given-names></name>
<name><surname>Foldi</surname><given-names>E</given-names></name>
<name><surname>Vanscheidt</surname><given-names>W</given-names></name>
<name><surname>Zschocke</surname><given-names>I</given-names></name>
</person-group>. <article-title>Development, validation and clinical use of the FLQA-I, a disease-specific quality of life questionnaire for patients with lymphedema</article-title>. <source>Vasa</source>. <year>2005</year>;<volume>34</volume>:<fpage>31</fpage>-<lpage>35</lpage>.</citation>
</ref>
<ref id="bibr56-1534734612438436">
<label>56.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Runowicz</surname><given-names>CD</given-names></name>
<name><surname>Passik</surname><given-names>SD</given-names></name>
<name><surname>Hann</surname><given-names>D</given-names></name><etal/>
</person-group>. <article-title>American Cancer Society Lymphedema Workshop. Workgroup II: patient education—pre- and posttreatment</article-title>. <source>Cancer</source>. <year>1998</year>;<volume>83</volume>(<issue>12 suppl</issue>):<fpage>2880</fpage>-<lpage>2881</lpage>.</citation>
</ref>
<ref id="bibr57-1534734612438436">
<label>57.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Augustin</surname><given-names>M</given-names></name>
<name><surname>Radtke</surname><given-names>MA</given-names></name>
<name><surname>Zschocke</surname><given-names>I</given-names></name><etal/>
</person-group>. <article-title>The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases</article-title>. <source>Arch Dermatol Res</source>. <year>2009</year>;<volume>301</volume>:<fpage>561</fpage>-<lpage>571</lpage>.</citation>
</ref>
<ref id="bibr58-1534734612438436">
<label>58.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Blome</surname><given-names>C</given-names></name>
<name><surname>Augustin</surname><given-names>M</given-names></name>
<name><surname>Behechtnejad</surname><given-names>J</given-names></name>
<name><surname>Rustenbach</surname><given-names>SJ</given-names></name>
</person-group>. <article-title>Dimensions of patient needs in dermatology: subscales of the patient benefit index</article-title>. <source>Arch Dermatol Res</source>. <year>2011</year>;<volume>303</volume>:<fpage>11</fpage>-<lpage>17</lpage>.</citation>
</ref>
<ref id="bibr59-1534734612438436">
<label>59.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vignes</surname><given-names>S</given-names></name>
<name><surname>Arrault</surname><given-names>M</given-names></name>
<name><surname>Dupuy</surname><given-names>A</given-names></name>
</person-group>. <article-title>Factors associated with increased breast cancer-related lymphedema volume</article-title>. <source>Acta Oncol</source>. <year>2007</year>;<volume>46</volume>:<fpage>1138</fpage>-<lpage>1142</lpage>.</citation>
</ref>
<ref id="bibr60-1534734612438436">
<label>60.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vignes</surname><given-names>S</given-names></name>
<name><surname>Porcher</surname><given-names>R</given-names></name>
<name><surname>Arrault</surname><given-names>M</given-names></name>
<name><surname>Dupuy</surname><given-names>A</given-names></name>
</person-group>. <article-title>Factors influencing breast cancer-related lymphedema volume after intensive decongestive physiotherapy</article-title>. <source>Support Care Cancer</source>. <comment>92011</comment>;<volume>19</volume>:<fpage>935</fpage>-<lpage>940</lpage>.</citation>
</ref>
<ref id="bibr61-1534734612438436">
<label>61.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Torres Lacomba</surname><given-names>M</given-names></name>
<name><surname>Yuste Sánchez</surname><given-names>MJ</given-names></name>
<name><surname>Zapico Goñi</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial</article-title>. <source>BMJ</source>. <year>2010</year>;<volume>340</volume>:<fpage>b5396</fpage>. doi: 10.1136/bmj.b5396<pub-id pub-id-type="doi">10.1136/bmj.b5396</pub-id>.</citation>
</ref>
<ref id="bibr62-1534734612438436">
<label>62.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Box</surname><given-names>RC</given-names></name>
<name><surname>Reul-Hirche</surname><given-names>HM</given-names></name>
<name><surname>Bullock-Saxton</surname><given-names>JE</given-names></name>
<name><surname>Furnival</surname><given-names>CM</given-names></name>
</person-group>. <article-title>Physiotherapy after breast cancer surgery: results of a randomised controlled study to minimise lymphoedema</article-title>. <source>Breast Cancer Res Treat</source>. <year>2002</year>;<volume>75</volume>:<fpage>51</fpage>-<lpage>64</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>